In PLIVA v. Mensing, 131 S. Ct. 2567 (2011), the Supreme Court held that FDA regulations governing the labeling of prescription drugs preempt state-law failure-to-warn claims against generic drug manufacturers. Here is a link to a recent article on Mensing and its implications.
Thanks to Public Citizen for the link.
No comments:
Post a Comment